Observing Queer Stories

Prohost Letter #418
Observing Queer Stories 

PORTOLA - Portola (PTLA) has been granted approval of an important factor Xa inhibitor Bevyxxa (betrixa-­ban for extended prophylaxis of venous thromboembolism (VTE) in acute medically ill patients with risk factors for a life-­threatening VTE . . .

This content is for paid subscribers.
Please click here to subscribe or log in.